Learn About Plasma Donation Testing Requirements

What Plasma Donation Testing Involves

Plasma donation centers perform multiple tests on both donors and their plasma to ensure safety for people who receive plasma-derived medications and treatments. Understanding these tests helps donors know what to expect during the screening process.

When you arrive at a plasma donation center, staff members will conduct both initial screening and ongoing testing. The initial screening happens before your first donation and includes a detailed medical history questionnaire. This questionnaire asks about your health conditions, medications, recent travel, tattoos, piercings, and other factors that might affect plasma safety. Be thorough and honest with these answers—they help protect both you and people who will receive your plasma.

Physical examination is part of the testing process. A healthcare worker will check your vital signs including blood pressure, heart rate, temperature, and respiratory rate. They will also examine your arms to ensure your veins are suitable for needle insertion. Your weight will be measured, as plasma donation volumes are calculated based on body weight—donors typically give between 625 and 850 milliliters of plasma per donation.

Blood tests form the core of plasma donation testing. These tests screen for infectious diseases that could be transmitted through plasma. Common tests include screening for HIV, hepatitis B and C, syphilis, and other bloodborne pathogens. Some centers also test for human T-lymphotropic virus (HTLV). These tests happen before your first donation and periodically afterward, depending on your donation frequency and local regulations.

Practical takeaway: Bring valid identification, proof of Social Security number, and proof of current address to your first appointment. Having these documents ready speeds up the screening process. Also, plan to spend 3-4 hours at your first visit because testing and paperwork take considerable time.

Pre-Donation Health Screening Requirements

Before donating plasma, donors must meet specific health requirements designed to protect both the donor and plasma recipients. These requirements vary slightly between centers but follow federal guidelines set by the FDA and other regulatory bodies.

Age and weight are basic requirements. Most plasma centers require donors to be at least 18 years old, though some states allow 16 and 17-year-olds with parental consent. Donors must typically weigh at least 110 pounds, with some centers requiring 120 pounds or more. These weight requirements exist because the amount of plasma collected depends on body weight—heavier donors can safely donate more plasma.

Donors must be in generally good health. This means you should not have serious acute illnesses at the time of donation. If you have a cold, fever, or active infection, you will be asked to reschedule. However, many chronic conditions do not automatically prevent plasma donation. People with well-controlled diabetes, high blood pressure, or thyroid conditions may still donate. Each situation is evaluated individually based on current health status and medication use.

Medication history is thoroughly reviewed during screening. Certain medications disqualify donors temporarily or permanently. For example, people taking isotretinoin (Accutane) for severe acne must wait one month after their last dose before donating. Those on finasteride (Propecia) for hair loss must wait one month. Some antibiotics require a waiting period of several days after completing treatment. Blood thinners like warfarin may prevent donation or require special consideration. Always inform staff about every medication and supplement you take.

Recent vaccinations and medical procedures are considered. If you received a live vaccine, you typically must wait 48 hours before donating. Certain inactivated vaccines may also require waiting periods. Dental work, surgery, or medical procedures may result in temporary deferral to ensure any infections are unlikely.

Practical takeaway: Create a list of all your medications, supplements, and recent medical events before your first appointment. This information helps staff quickly determine whether you meet requirements and prevents delays during screening.

Infectious Disease Testing and Screening Standards

Infectious disease testing is the most rigorous aspect of plasma donation screening. Federal regulations require testing for multiple diseases that could be transmitted through plasma transfusions or plasma-derived products. Understanding these tests helps donors know why they matter.

HIV (Human Immunodeficiency Virus) testing is mandatory. Centers use antibody tests that detect the immune response to HIV. Modern tests can detect HIV within days of infection, though there is a "window period" when someone recently infected might test negative. For this reason, donors are also asked detailed questions about behaviors that increase HIV risk. The FDA's current guidelines recommend using fourth-generation antigen/antibody tests that can detect HIV about 18 days after infection.

Hepatitis B and C screening is required. Hepatitis B testing looks for hepatitis B surface antigen (HBsAg), which indicates current infection. The test can detect infection within 45 days after someone is exposed. Hepatitis C testing uses antibody tests that detect whether someone has had hepatitis C. Because hepatitis C antibodies remain in the blood even after treatment, donors with a history of hepatitis C are typically deferred.

Syphilis screening tests for Treponema pallidum, the bacterium that causes syphilis. These tests are performed on every donation, not just the first one. Syphilis can be transmitted through blood products, and the infection can be serious if untreated. Modern treatments exist for syphilis, but donors must complete treatment and meet specific waiting periods before donating again.

Human T-lymphotropic virus (HTLV) testing screens for HTLV-I and HTLV-II. These viruses can cause serious neurological diseases years after infection. Testing for HTLV has been required since the 1990s and has significantly reduced transmission risk through blood products.

West Nile Virus testing is performed during certain seasons when transmission risk is higher. This testing expanded in the early 2000s after cases were identified in blood recipients. The virus is primarily transmitted by mosquitoes, so testing becomes more important during summer and early fall months in most regions.

Practical takeaway: Ask your donation center which specific tests they perform. Different centers may include additional tests based on local disease patterns or their parent company's standards. Knowing what tests you received helps you understand your health status and any results they discuss with you.

Understanding Test Results and Follow-Up Requirements

After testing, plasma centers communicate results to donors, though the process and timeline vary. Understanding how results work helps donors know what to expect and what different outcomes mean.

Negative test results mean the screening did not detect the disease being tested for. For most donors, all tests come back negative, and they can proceed with regular plasma donations. However, negative results do not mean zero risk—they reflect the current test capabilities and the window period between infection and test detection. This is why plasma centers also rely on donor history questions.

Reactive or positive results require follow-up testing. If initial screening is positive, the center will typically perform additional confirmatory tests before informing the donor. Some reactive results are false positives—meaning the initial test suggested disease when none is actually present. Confirmatory testing clarifies whether someone truly has the condition. The center will contact you with results and next steps if follow-up testing is needed.

If you test positive for an infectious disease, you will be deferred from donating. Deferral means you cannot donate plasma at that time. Some deferrals are temporary—you may become eligible again after treatment or after a certain waiting period. For example, if you test positive for hepatitis B but recover completely, you might be deferred permanently because of the small risk of reactivation. Each situation depends on the specific disease and medical guidelines.

Repeat testing occurs at each donation visit for some infections. Every time you donate, centers retest you for diseases like syphilis and HIV. This is done partly because risks change over time and partly because early detection is crucial. The frequency of testing depends on donation frequency and which diseases are being monitored.

Some donors receive indefinite deferrals. If someone tests positive for HIV, hepatitis B or C, or certain other infections, they are typically deferred permanently. This protects plasma recipients from receiving contaminated plasma. If you receive an indefinite deferral, ask for specific information about why and whether future changes to your status might affect the deferral.

Practical takeaway: Ask the center to explain any test results in person. If you receive a deferral, request written information about the reason and any steps you might take if circumstances change. Keep this documentation in case you want to donate at a different center or need to discuss it with your doctor.